ArticleThe American journal of case reports2025
Refractory Renovascular Hypertension from Paraganglioma: A Case Report.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Accurate diagnosis and effective management of secondary hypertension can be challenging. Renovascular hypertension is a common etiology of secondary hypertension. Pheochromocytomas and paragangliomas are neuroendocrine tumors that secrete catecholamines, which are rarer causes of secondary hypertension. The combination of these 2 conditions is even rarer, but should not be overlooked. CASE REPORT Here, we present the case of a young woman with hyper-reninemic hypertension caused by unilateral renal artery stenosis, which recurred despite percutaneous transluminal renal angioplasty. An ipsilateral renal artery aneurysm was found as a complication at the time of recurrence of renal artery stenosis. Ultimately, a paraganglioma compressing the right renal artery was identified as the underlying cause. Following a successful second balloon angioplasty for renal artery stenosis, coil embolization for renal artery aneurysm, and subsequent surgical resection of the paraganglioma, the patient remained normotensive for 6 years without requiring antihypertensive medication. The decrease in plasma renin activity after percutaneous transluminal renal angioplasty and the subsequent improvement in hypertension prior to tumor resection suggest that renal artery stenosis was the primary cause of her hypertension. CONCLUSIONS Although rare, paraganglioma must be included as a potential cause of renovascular hypertension, particularly in cases with persistent or recurrent renal artery stenosis. Because of the concomitant renal artery aneurysm, we prioritized percutaneous coil embolization to reduce the risk of aneurysm rupture during tumor resection. This strategic approach allowed us to safely resect the paraganglioma while minimizing potential perioperative complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.